Craft

Invion

Stock Price

$0

2024-10-04

Market Capitalization

$27.1 M

2024-10-04

Invion Summary

Company Summary

Overview
Invion is a life-sciences company specializing in photodynamic therapy (PDT). It is engaged in the research and development of the Photosoft technology for the treatment of a range of cancers. In addition, the company develops PDT with photosensitiser IVX-PDT based on the Photosoft technology to improve the treatment of skin cancers and hard-to-treat solid cancers, including lung, prostrate, ovarian, and mesothelioma.
Type
Public
Status
Active
Founded
2012
HQ
Kew East, AU | view all locations
Website
http://inviongroup.com/
Cybersecurity rating
Sectors

Key People

  • Alan Yamashita, Non-Executive Director

    • Thian Chew, Executive Chair and CEO

      • Rob Merriel, Non-Executive Director

        • Alistair Bennallack, Non-Executive Director

          LocationsView all

          2 locations detected

          • Kew East, VIC HQ

            Australia

            692 High St

          • South Melbourne, VIC

            Australia

            100 Albert Rd

          Invion Financials

          Summary Financials

          Gross profit (H1, 2026)
          $1.0K
          Net income (H1, 2026)
          ($3.6M)
          Cash (H1, 2026)
          $137.0K
          EBIT (H1, 2026)
          ($3.5M)
          Enterprise value
          $27.8M

          Footer menu